AHC vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

AHC

AUS HEALTH FPO [AHC]

60MEDIUM-HIGH

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

AHC EYE
Technical
76
46
Catalyst
55
54
Sentiment
50
50
Fundamental
99
60
Momentum
49
65
Risk Gate
50
50

Key Metrics

AHC Metric EYE
$97.4MMarket Cap$38.5M
225KAvg Volume (20d)199K
N/AShort InterestN/A
$0.44552-Week High$0.205
$0.19352-Week Low$0.100
+6.1%Daily Change+3.8%
$0.260Reference Price$0.135
+15.8%ROE-26.1%
+9.6%Profit Margin-12.4%

Active Signals

AHC Signals

MACD momentum is picking up steam
Pressing against the upper Bollinger Band — extended and may need to cool off
Trading above both moving averages — the trend is your friend here
Volume surging at 3.7x normal while price climbs — real buying conviction behind this move
Knocking on the door of resistance — if it punches through, things could get interesting
Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive

EYE Signals

Stochastic just turned bullish from a low level — early reversal sign
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.2 quarters)
Low P/S ratio (1.1x)
Moderate revenue growth (+11%)
EPS estimates revised upward (+10pts)
Small-cap ($20-100M)

Ask Scout AI to compare AHC and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs ATH →ARX vs MVP →ATX vs CUV →ATX vs MVP →BLS vs CUV →
AHC Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).